Califf Optimistic As He Departs US FDA
Outgoing commissioner highlights efforts to improve staff, says bucket list mostly accomplished. Agency now faces hiring freeze challenge.
You may also be interested in...
The most questions were asked about issues such as accelerated approval and clinical trials, not Gottlieb's ties to industry.
Analyst poll of 53 drug companies indicates broad support for Scott Gottlieb compared to three other known candidates for FDA Commissioner.
In an interview, Joseph Gulfo, former medtech industry CEO and vocal FDA critic, outlines his worldview and interest in pushing aggressively against increasing the FDA ‘body of law.’